Avoidance of adjuvant radiotherapy in selected patients with invasive breast cancer

Annals of Surgical Oncology

Volumn 11, Issue 3, 2004, Pages 316-321

  Lee, Susan H ^a   Chung, Maureen A ^a,b   Chelmow, David ^a,c   Cady, Blake ^a,b,d  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d University Surgical Associates   (United States)

Author keywords

Breast cancer; Lumpectomy; Radiation; Recurrence

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST DUCT; BREAST SURGERY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROGNOSIS; RECURRENT CANCER; TREATMENT CONTRAINDICATION; ADJUVANT THERAPY; BREAST TUMOR; CANCER STAGING; FOLLOW UP; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 2442665653     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.07.001     Document Type: Article

References (11)

1. Blamey RW. The British Association of Surgical Oncology Trial (BASO II) of the treatment of small differentiated node negative tumors (abstract). Breast Cancer Res Treat 1999;47:50.
2. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 1996;88:1659-64.
3. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
4. Forrest AP, Stewart HJ, Everington D, et al. Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996;348:708-13.
5. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized trial. Br J Cancer 2001;84:164-9.
6. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999;17:2326-33.
7. Renton SC, Gazet JC, Ford HT, et al. The important resection margin in conservation surgery for breast cancer. Eur J Surg Oncol 1996;22:17-22.
8. Spooner D, Morrison JM, Oates GD, et al. The role of radiotherapy in early breast cancer (stage I). A West Midlands Breast Group prospective randomized collaborative study (BR 3002). Breast 1995;4:231.
9. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003.
10. Wolmark N, Digman J, Margolese R, et al. The role of radiotherapy and tamoxifen in the management of node negative invasive breast cancer-1.0 cm treated with lumpectomy: preliminary results of NSABP protocol B-21 (abstract). Proc Am Soc Clin Oncol 2000;19:70a.
11. Silverstein MJ. The University of Southern California/Van Nuys prognostic index. In: Silverstein MJ, ed. Ductal Carcinoma In Situ of the Breast. Philadelphia: Lippincott Williams & Wilkins, 2002: 464-5.